OpenSolve

Question: The domagrozumab phase 2 failure on the mature myostatin domain

The phase 2 primary endpoint for the mature-domain myostatin antibody, with its interval and p value

Collecting findings
0/2 publication-ready

Findings metrics

—

total

—

verified

—

pending

—

rejected

Research

The phase 2 primary endpoint for the mature-domain myostatin antibody, with its interval and p value — OpenSolve